Terms: = Breast cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
121 results:
1. Diabetes risk reduction diet and ovarian cancer risk: an Italian case-control study.
Esposito G; Turati F; Parazzini F; Augustin LSA; Serraino D; Negri E; La Vecchia C
Cancer Causes Control; 2023 Sep; 34(9):769-776. PubMed ID: 37221355
[TBL] [Abstract] [Full Text] [Related]
2. Diphenyl disulfide potentiates the apoptosis of breast cancer cells through Bax proteolytic activation with accompanying autophagy.
Chen SY; Chiu CC; Hung CT; Pan WH; Chen YC; Bow YD; Li WJ; Hsu SK; Lin IL; Wen ZH; Wu CY
Environ Toxicol; 2023 Aug; 38(8):2022-2030. PubMed ID: 37163415
[TBL] [Abstract] [Full Text] [Related]
3. Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative breast cancer.
Cao Y; Ge X; Zhu X; Han Y; Wang P; Akakuru OU; Wu A; Li J
Adv Sci (Weinh); 2023 Jul; 10(21):e2300545. PubMed ID: 37147783
[TBL] [Abstract] [Full Text] [Related]
4. cancer Risk Associated With
Cummings S; Alfonso A; Hughes E; Kucera M; Mabey B; Singh N; Eng C
JCO Precis Oncol; 2023 Jan; 7():e2200415. PubMed ID: 36634299
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Kawaguchi H; Yamamoto Y; Saji S; Masuda N; Nakayama T; Aogi K; Anan K; Ohtani S; Sato N; Takano T; Tokunaga E; Nakamura S; Hasegawa Y; Hattori M; Fujisawa T; Morita S; Yamaguchi M; Yamashita T; Yotsumoto D; Toi M; Ohno S
Jpn J Clin Oncol; 2023 Mar; 53(3):203-211. PubMed ID: 36484305
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours.
Goh JJH; Goh CJH; Lim QW; Zhang S; Koh CG; Chiam KH
Sci Rep; 2022 Dec; 12(1):20902. PubMed ID: 36463288
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract] [Full Text] [Related]
8. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract] [Full Text] [Related]
9. Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk.
Goldberg M; McDonald JA; Houghton LC; Andrulis IL; Knight JA; Bradbury AR; Schwartz LA; Buys SS; Frost CJ; Daly MB; John EM; Keegan THM; Chung WK; Wei Y; Terry MB
Int J Epidemiol; 2023 Feb; 52(1):272-283. PubMed ID: 35613015
[TBL] [Abstract] [Full Text] [Related]
10. Patient-Derived In Vitro and In Vivo Models of cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract] [Full Text] [Related]
11. Discriminating Neoplastic from Nonneoplastic Tissues Using an miRNA-Based Deep cancer Classifier.
Kaczmarek E; Pyman B; Nanayakkara J; Tuschl T; Tyryshkin K; Renwick N; Mousavi P
Am J Pathol; 2022 Feb; 192(2):344-352. PubMed ID: 34774515
[TBL] [Abstract] [Full Text] [Related]
12. AFP peptide (AFPep) as a potential growth factor for prostate cancer.
Zhu Z; West GR; Wang DC; Collins AB; Xiao H; Bai Q; Mesfin FB; Wakefield MR; Fang Y
Med Oncol; 2021 Nov; 39(1):2. PubMed ID: 34739644
[TBL] [Abstract] [Full Text] [Related]
13. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.
Li Q; Jiang B; Guo J; Shao H; Del Priore IS; Chang Q; Kudo R; Li Z; Razavi P; Liu B; Boghossian AS; Rees MG; Ronan MM; Roth JA; Donovan KA; Palafox M; Reis-Filho JS; de Stanchina E; Fischer ES; Rosen N; Serra V; Koff A; Chodera JD; Gray NS; Chandarlapaty S
Cancer Discov; 2022 Feb; 12(2):356-371. PubMed ID: 34544752
[TBL] [Abstract] [Full Text] [Related]
14. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.
Bai F; Zhang LH; Liu X; Wang C; Zheng C; Sun J; Li M; Zhu WG; Pei XH
Theranostics; 2021; 11(17):8218-8233. PubMed ID: 34373738
[No Abstract] [Full Text] [Related]
15. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
[TBL] [Abstract] [Full Text] [Related]
16. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Baxter JS; Johnson N; Tomczyk K; Gillespie A; Maguire S; Brough R; Fachal L; Michailidou K; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Brucker SY; Cai Q; Campa D; Canzian F; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Colonna S; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Fasching PA; Figueroa J; Flyger H; Gago-Dominguez M; Gao C; García-Closas M; García-Sáenz JA; Ghoussaini M; Giles GG; Goldberg MS; González-Neira A; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Hall P; Hamann U; Hartman M; Hatse S; Hauke J; Hollestelle A; Hoppe R; Hopper JL; Hou MF; ; ; Ito H; Iwasaki M; Jager A; Jakubowska A; Janni W; John EM; Joseph V; Jung A; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kosma VM; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Larson NL; Larsson SC; Le Marchand L; Lejbkowicz F; Li J; Long J; Lophatananon A; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Matsuo K; Mavroudis D; Mayes R; Menon U; Milne RL; Mohd Taib NA; Muir K; Muranen TA; Murphy RA; Nevanlinna H; O'Brien KM; Offit K; Olson JE; Olsson H; Park SK; Park-Simon TW; Patel AV; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Rack B; Rennert G; Romero A; Ruebner M; Rüdiger T; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Shah M; Shen CY; Shu XO; Simard J; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Toland AE; Tomlinson I; Truong T; Tseng CC; Untch M; Vachon CM; van den Ouweland AMW; Wang SS; Weinberg CR; Wendt C; Winham SJ; Winqvist R; Wolk A; Wu AH; Yamaji T; Zheng W; Ziogas A; Pharoah PDP; Dunning AM; Easton DF; Pettitt SJ; Lord CJ; Haider S; Orr N; Fletcher O
Am J Hum Genet; 2021 Jul; 108(7):1190-1203. PubMed ID: 34146516
[TBL] [Abstract] [Full Text] [Related]
17. The use of genomic assays reduces rates of chemotherapy: a single-institution experience.
Vatish J; Wilkinson B; Al-Ishaq Z; Pujji O; Isgar B; Vidya R; Matey P; Sircar T; Mylvaganam S
Ir J Med Sci; 2022 Apr; 191(2):687-690. PubMed ID: 33993406
[TBL] [Abstract] [Full Text] [Related]
18. Design and evaluation of peptide-18-targeted nanoliposomes constructed by poly(2-oxazoline)-DOPE for doxorubicin delivery.
Devrim B; Bolat ZB; Telci D; Şahin F; Gulyuz S; Ozkose UU; Yilmaz O; Bozkır A
J Microencapsul; 2021 Aug; 38(5):285-297. PubMed ID: 33853478
[TBL] [Abstract] [Full Text] [Related]
19. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
Bai F; Liu S; Liu X; Hollern DP; Scott A; Wang C; Zhang L; Fan C; Fu L; Perou CM; Zhu WG; Pei XH
Breast Cancer Res; 2021 Jan; 23(1):10. PubMed ID: 33478572
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells.
Bostanabad SY; Noyan S; Dedeoglu BG; Gurdal H
Sci Rep; 2021 Jan; 11(1):1539. PubMed ID: 33452359
[TBL] [Abstract] [Full Text] [Related]
[Next]
